The Last Trade || ASX Up 0.25% At Close; Gold Miners, Tech Stocks Lead

This is the last show of the day - The Last Trade. Lets get started with today’s market close commentary.

• The share price of drug developer Acrux Limited fell as much as 10.71% to 12.5 Australian cents, after US-based pharma firm Almirall LLC initiated a patent litigation against the company in a US District Court of New Jersey. 

• Boart Longyear Limited shares dropped 3.1% to 31 Australian cents after the company received consent for US$65 million additional financing. It has received consents from the holders of 99.75% of the Senior Secured Notes (SSN), due December 2022, for amendment to SSN. The current rate of interest is 10% on SSN. The interest entitlement for those noteholders who agreed will be 14.5% for 30 June 2021. 

• Aeris Resources Limited (Aeris) shares surged 20% to 21 Australian cents after the company provided an update on exploration activities at the Constellation deposit. It is located within the company’s 100% owned Tritton tenement package in New South Wales. 

• Universal Biosensors, Inc shared it has recently made first sales of its Sentia device and free SO2 test strips to companies operating in France, Italy, Germany, Spain, Portugal and Switzerland. Following the announcement, shares of the company rises 3.8% to 68.5 Australian cents. 


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK